Prednisolone acetate
- Generic Name
- Prednisolone acetate
- Brand Names
- Blephamide, Econopred Plus, Flo-pred, Pred Forte, Pred Mild, Pred-G
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30O6
- CAS Number
- 52-21-1
- Unique Ingredient Identifier
- 8B2807733D
- Background
Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond.
Prednisolone acetate was granted FDA approval in 1955.
- Indication
Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions. Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.
- Associated Conditions
- Inflammation, Inflammatory Conditions, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Transplanted Organ Rejection
- Associated Therapies
- -
A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
- Conditions
- Interventions
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- VivaVision Biotech, Inc
- Target Recruit Count
- 120
- Registration Number
- NCT06679153
Research on the Treatment of Severe Community-acquired Pneumonia in Children
- First Posted Date
- 2023-03-14
- Last Posted Date
- 2023-03-14
- Lead Sponsor
- Baoping XU
- Target Recruit Count
- 160
- Registration Number
- NCT05768204
- Locations
- 🇨🇳
Baoding Children's Hospital, Baoding, China
🇨🇳Beijing Children's Hospital, Beijing, China
🇨🇳Beijing Fangshan District Health Care Hospital, Beijing, China
DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia
- First Posted Date
- 2022-11-17
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Duke University
- Target Recruit Count
- 30
- Registration Number
- NCT05620901
- Locations
- 🇺🇸
Duke Eye Center, Durham, North Carolina, United States
The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2022-10-24
- Target Recruit Count
- 50
- Registration Number
- NCT05461261
- Locations
- 🇨🇳
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, Jiangsu, China
Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL
- Conditions
- Interventions
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Sight Medical Doctors PLLC
- Target Recruit Count
- 30
- Registration Number
- NCT04863742
- Locations
- 🇺🇸
SightMD, LIASC, Brentwood, New York, United States
Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
- Conditions
- Interventions
- First Posted Date
- 2020-09-24
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Retina Vitreous Associates of Florida
- Target Recruit Count
- 10
- Registration Number
- NCT04563299
- Locations
- 🇺🇸
Retina Vitreous Associates of Florida, Saint Petersburg, Florida, United States
Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- Midwest Eye Institute
- Target Recruit Count
- 7
- Registration Number
- NCT04464629
- Locations
- 🇺🇸
Midwest Eye Institute, Indianapolis, Indiana, United States
Dextenza for Post-operative Treatment of Pterygium
- Conditions
- Interventions
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Brandon Eye Associates, PA
- Target Recruit Count
- 20
- Registration Number
- NCT04351737
- Locations
- 🇺🇸
Brandon Eye Associates, Brandon, Florida, United States
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
- Conditions
- Interventions
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- Research Insight LLC
- Target Recruit Count
- 31
- Registration Number
- NCT04273282
- Locations
- 🇺🇸
Ophthalmic Consultants of Long Island, Garden City, New York, United States
🇺🇸Harvard Eye Associates, Laguna Hills, California, United States
Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study
- Conditions
- Interventions
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Sight Medical Doctors PLLC
- Target Recruit Count
- 20
- Registration Number
- NCT04168112
- Locations
- 🇺🇸
SightMD, Babylon, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.